Crossref
Phenotypic Extended-Spectrum Beta-Lactamase (ESBL) Burden, Multidrug Resistance, and Beta-Lactamase Inhibitor Failure Across Clinical Acinetobacter Species
Cureus · 21.11.2026
DOI: 10.7759/cureus.120064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 21.11.2026. Verfasst von Pranay R Ullengala und 2 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ullengala, P. R., Shinde, R. V., & Patil, S. (2026). Phenotypic Extended-Spectrum Beta-Lactamase (ESBL) Burden, Multidrug Resistance, and Beta-Lactamase Inhibitor Failure Across Clinical Acinetobacter Species. Cureus. https://doi.org/10.7759/cureus.120064
Vancouver
Ullengala PR, Shinde RV, Patil S. Phenotypic Extended-Spectrum Beta-Lactamase (ESBL) Burden, Multidrug Resistance, and Beta-Lactamase Inhibitor Failure Across Clinical Acinetobacter Species. Cureus. 2026. doi:10.7759/cureus.120064
BibTeX
@article{Ullengala2026,
author = {Ullengala, Pranay R and Shinde, Ravindra V and Patil, Satish},
title = {Phenotypic Extended-Spectrum Beta-Lactamase (ESBL) Burden, Multidrug Resistance, and Beta-Lactamase Inhibitor Failure Across Clinical Acinetobacter Species},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.120064}
}
EUVIMED